Two Sigma Investments’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-105,700
| Closed | -$2.55M | – | 3345 |
|
|
2023
Q1 | $2.55M | Sell |
105,700
-485,130
| -82% | -$11.7M | 0.01% | 1181 |
|
|
2022
Q4 | $6.25M | Buy |
590,830
+431,108
| +270% | +$4.56M | 0.02% | 726 |
|
|
2022
Q3 | $719K | Buy |
159,722
+99,995
| +167% | +$450K | ﹤0.01% | 1562 |
|
|
2022
Q2 | $239K | Buy |
59,727
+43,127
| +260% | +$173K | ﹤0.01% | 2041 |
|
|
2022
Q1 | $122K | Buy |
+16,600
| New | +$122K | ﹤0.01% | 2371 |
|
|
2021
Q4 | – | Sell |
-93,600
| Closed | -$599K | – | 3286 |
|
|
2021
Q3 | $599K | Buy |
93,600
+57,000
| +156% | +$365K | ﹤0.01% | 1932 |
|
|
2021
Q2 | $309K | Sell |
36,600
-500,720
| -93% | -$4.23M | ﹤0.01% | 2117 |
|
|
2021
Q1 | $5.64M | Buy |
537,320
+148,619
| +38% | +$1.56M | 0.01% | 772 |
|
|
2020
Q4 | $6.59M | Sell |
388,701
-161,631
| -29% | -$2.74M | 0.02% | 639 |
|
|
2020
Q3 | $7.06M | Buy |
550,332
+379,956
| +223% | +$4.88M | 0.03% | 513 |
|
|
2020
Q2 | $2.4M | Buy |
+170,376
| New | +$2.4M | 0.01% | 811 |
|